Free Trial

Amplifon (OTCMKTS:AMFPF) Reaches New 12-Month Low - What's Next?

Amplifon logo with Medical background

Key Points

  • Amplifon S.p.A. has reached a new 52-week low, trading at $16.11, down from a previous close of $18.33.
  • The company reported a missed earnings per share estimate of $0.25, against a consensus estimate of $0.34, despite high revenue of $698.20 million.
  • Morgan Stanley maintains an "overweight" rating on Amplifon, indicating a generally positive outlook despite recent stock performance.
  • Five stocks to consider instead of Amplifon.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $16.11 and last traded at $16.11, with a volume of 397 shares trading hands. The stock had previously closed at $18.33.

Analyst Ratings Changes

Separately, Morgan Stanley restated an "overweight" rating on shares of Amplifon in a research report on Wednesday, June 25th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy".

Check Out Our Latest Stock Report on Amplifon

Amplifon Trading Down 12.1%

The company has a market capitalization of $3.63 billion, a P/E ratio of 26.41 and a beta of 0.35. The stock's 50 day moving average is $18.77 and its 200-day moving average is $20.81. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.61 and a quick ratio of 0.53.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.25 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.09). Amplifon had a return on equity of 13.70% and a net margin of 5.20%.The company had revenue of $698.20 million during the quarter, compared to the consensus estimate of $625.73 million.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.